MYGN Historical Earnings image   This MYGN historical earnings page last updated 11/7/2022
MYGN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.18B
Q1 20225/5/20220.16B
Q4 20212/24/20220.16B
Q3 202111/2/20210.17B
Q2 20218/3/20210.19B
Q1 20215/3/20210.17B
Q2 20212/23/20210.15B
Q1 202111/9/20200.15B
Q4 20208/13/20200.09B
Q3 20205/5/20200.16B
Q2 20202/6/20200.20B
Q1 202011/4/20190.19B
Q4 20198/13/20190.22B
Q3 20195/7/20190.22B
Q2 20192/5/2019216.80M
Q1 201911/6/2018202.30M
Q4 20188/21/2018200.90M
Q3 20185/8/2018193.50M
Q2 20182/6/2018194.00M
Q1 201811/7/2017190.20M
Q4 20178/8/2017200.50M
Q3 20175/2/2017196.90M
Q2 20172/7/2017196.50M
Q1 201711/1/2016177.50M
Q4 20168/9/2016186.50M
Q3 20165/3/2016190.50M
Q2 20162/2/2016193.30M
Q1 201611/3/2015183.50M
Q4 20158/11/2015189.90M
Q3 20155/5/2015179.99M
Q2 20152/3/2015184.39M
Q1 201511/4/2014168.80M
Q4 20148/12/2014188.80M
Q3 20145/6/2014182.90M
Q2 20142/4/2014204.10M
Q1 201411/5/2013202.50M
Q4 20138/13/2013174.10M
Q3 20135/7/2013156.50M
Q2 20132/5/2013149.10M
Q1 201311/5/20120.13B
Q4 20128/14/2012133.00M
Q3 20125/1/2012129.78M
Q2 20121/31/2012122.81M
Q1 201211/1/2011110.45M
MYGN Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/4/20220.040
Q1 20225/5/2022-0.030
Q4 20212/24/2022-0.020
Q3 202111/2/2021-0.020
Q2 20218/3/20210.120
Q1 20215/3/2021-0.060
Q2 20212/23/2021-0.120
Q1 202111/9/2020-0.150
Q4 20208/13/2020-0.310
Q3 20205/5/2020-0.080
Q2 20202/6/20200.230
Q1 202011/4/20190.080
Q4 20198/13/20190.410
Q3 20195/7/20190.460
Q2 20192/5/20190.38
Q1 201911/6/20180.43
Q4 20188/21/20180.38
Q3 20185/8/20180.31
Q2 20182/6/20180.31
Q1 201811/7/20170.26
Q4 20178/8/20170.3
Q3 20175/2/20170.27
Q2 20172/7/20170.26
Q1 201711/1/20160.23
Q4 20168/9/20160.36
Q3 20165/3/20160.41
Q2 20162/2/20160.45
Q1 201611/3/20150.41
Q4 20158/11/20150.41
Q3 20155/5/20150.4
Q2 20152/3/20150.4
Q1 201511/4/20140.25
Q4 20148/12/20140.48
Q3 20145/6/20140.48
Q2 20142/4/20140.66
Q1 201411/5/20130.68
Q4 20138/13/20130.53
Q3 20135/7/20130.46
Q2 20132/5/20130.42
Q1 201311/5/20120.360
Q4 20128/14/20120.34
Q3 20125/1/20120.34
Q2 20121/31/20120.33
Q1 201211/1/20110.29
Quotes delayed 20 minutes

Email EnvelopeFree MYGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Myriad Genetics (MYGN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MYMD Historical Earnings
NAOV Historical Earnings
NARI Historical Earnings
NATR Historical Earnings
NBIX Historical Earnings
NBSE Historical Earnings
NDRA Historical Earnings
NEO Historical Earnings
NEOG Historical Earnings
NERV Historical Earnings
What was the record high MYGN historical earnings result?
In terms of earnings or revenue, what is the best MYGN historical earnings result that Myriad Genetics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest MYGN historical earnings result was set in Q1 2014, when Myriad Genetics posted results of 0.68/share. The most successful revenue quarter within our data set was Q2 2019 when Myriad Genetics reported revenue of 216.80M.

What was the lowest Myriad Genetics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest MYGN has reported, and when?

✔️Accepted answer: Within our data set, the lowest MYGN historical earnings result was set in Q4 2020, when Myriad Genetics posted results of -0.310/share. The smallest revenue quarter within our data set was Q4 2020 when Myriad Genetics reported revenue of 0.09B.

On this page we presented the MYGN historical earnings date information for Myriad Genetics. Reviewing that MYGN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2014, when MYGN posted adjusted EPS of 0.68/share. Meanwhile the lowest MYGN historical earnings result was in Q4 2020, when MYGN posted adjusted EPS of -0.310/share. Moving to Myriad Geneticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2019 when MYGN reported 216.80M in revenue, while the smallest revenue quarter was Q4 2020 when MYGN reported 0.09B in revenue.

For self directed investors doing their due diligence on MYGN or any other given stock, their research can benefit from looking into all of the Myriad Genetics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Myriad Genetics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for MYGN. Thanks for visiting, and the next time you need to research MYGN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: DVN Videos, Funds Holding IYE, Funds Holding ARGU.

 

MYGN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.